---
title: "CODX.US (CODX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CODX.US/news.md"
symbol: "CODX.US"
name: "CODX.US"
parent: "https://longbridge.com/en/quote/CODX.US.md"
datetime: "2026-05-20T01:47:04.184Z"
locales:
  - [en](https://longbridge.com/en/quote/CODX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CODX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CODX.US/news.md)
---

# CODX.US (CODX.US) — Related News

### [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://longbridge.com/en/news/286969790.md)
*2026-05-19T21:06:03.000Z*
> In Tuesday's after-market session, Co-Diagnostics shares surged 20.8% to $2.38, while Celldex Therapeutics rose 16.05% t

### [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
*2026-05-19T19:20:13.000Z*
> Co-Diagnostics Inc. (CODX) has developed a Bundibugyo virus assay for rapid detection amid escalating Ebola outbreak ale

### [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://longbridge.com/en/news/286948585.md)
*2026-05-19T17:06:30.000Z*
> On Tuesday, Med Pharmaceuticals (NASDAQ:INM) saw a 127% increase to $1.54, while MetaVia (NASDAQ:MTVA) rose 58.54% to $1

### [09:00 ETCo-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert](https://longbridge.com/en/news/286917745.md)
*2026-05-19T13:02:18.000Z*
> Co-Diagnostics, Inc. has developed an assay strategy for the Bundibugyo virus (BDBV) following the recent Ebola outbreak

### [Co-Diagnostics | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 145.95 K](https://longbridge.com/en/news/286462878.md)
*2026-05-14T20:24:20.000Z*
### [Co-Diagnostics | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 145.95 K](https://longbridge.com/en/news/286460706.md)
*2026-05-14T20:11:41.000Z*